Cargando…

Positioning High-Throughput CETSA in Early Drug Discovery through Screening against B-Raf and PARP1

Methods to measure cellular target engagement are increasingly being used in early drug discovery. The Cellular Thermal Shift Assay (CETSA) is one such method. CETSA can investigate target engagement by measuring changes in protein thermal stability upon compound binding within the intracellular env...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Joseph, Dale, Ian, Hemsley, Paul, Leach, Lindsey, Dekki, Nancy, Orme, Jonathan P., Talbot, Verity, Narvaez, Ana J., Bista, Michal, Martinez Molina, Daniel, Dabrowski, Michael, Main, Martin J., Gianni, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484527/ https://www.ncbi.nlm.nih.gov/pubmed/30543471 http://dx.doi.org/10.1177/2472555218813332

Ejemplares similares

Current Advances in CETSA
por: Tolvanen, Tuomas Aleksi
Publicado: (2022)

A widely-applicable high-throughput cellular thermal shift assay (CETSA) using split Nano Luciferase
por: Martinez, Natalia J., et al.
Publicado: (2018)

CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
por: Langebäck, Anette, et al.
Publicado: (2019)

Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA
por: Sun, Wendi, et al.
Publicado: (2019)

CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil
por: Almqvist, Helena, et al.
Publicado: (2016)

Identification of antimalarial targets of chloroquine by a combined deconvolution strategy of ABPP and MS-CETSA
por: Gao, Peng, et al.
Publicado: (2022)

CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
por: Ishii, Tsuyoshi, et al.
Publicado: (2017)

The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
por: Alshareef, Abdulraheem, et al.
Publicado: (2016)

Determining direct binders of the Androgen Receptor using a high-throughput Cellular Thermal Shift Assay
por: Shaw, Joseph, et al.
Publicado: (2018)

High throughput molecular dynamics for drug discovery
por: Stanley, Nathaniel, et al.
Publicado: (2015)

Capsaicin Targets tNOX (ENOX2) to Inhibit G1 Cyclin/CDK Complex, as Assessed by the Cellular Thermal Shift Assay (CETSA)
por: Islam, Atikul, et al.
Publicado: (2019)

RAF inhibitors promote RAS-RAF interaction by allosterically disrupting RAF autoinhibition
por: Jin, Ting, et al.
Publicado: (2017)

Structure-Guided Design and In-Cell Target Profiling of a Cell-Active Target Engagement Probe for PARP Inhibitors
por: Howard, Ryan T., et al.
Publicado: (2020)

Discovery of an NAD(+) analogue with enhanced specificity for PARP1
por: Zhang, Xiao-Nan, et al.
Publicado: (2022)

Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling Pathway
por: Zhao, Jingtong, et al.
Publicado: (2022)

Targeting the Raf kinases in human cancer: the Raf dimer dilemma
por: Durrant, David E, et al.
Publicado: (2018)

Discovery of New Quinolone-Based Diarylamides as Potent B-RAF(V600E)/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity
por: Kim, Hyun Ji, et al.
Publicado: (2023)

Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction
por: Durrant, David E., et al.
Publicado: (2021)

“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014)

Fertility of Spiny-Cheek Crayfish (Orconectes limosus Raf.) from the Vistula Lagoon
por: Graczyk, Radomir, et al.
Publicado: (2019)

NF-κB signaling mediates acquired resistance after PARP inhibition
por: Nakagawa, Yuko, et al.
Publicado: (2015)

RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF
por: Poulikakos, Poulikos I., et al.
Publicado: (2010)

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014)

Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain
por: Travers, Timothy, et al.
Publicado: (2018)

Miniaturized drug discovery and high throughput microarrays for biological discovery
por: Diamond, Scott L.
Publicado: (2006)

High-Throughput Strategies for the Discovery of Anticancer Drugs by Targeting Transcriptional Reprogramming
por: Huang, Lijun, et al.
Publicado: (2021)

High-Throughput Screening for Biomarker Discovery
por: Janvilisri, Tavan, et al.
Publicado: (2015)

Raf-1 regulates migration
por: Tuma, Rabiya S.
Publicado: (2005)

Resistance to RAF inhibitors revisited
por: Hartsough, Edward, et al.
Publicado: (2013)

Arabidopsis Raf-Like Kinase Raf10 Is a Regulatory Component of Core ABA Signaling
por: Nguyen, Quy Thi Cam, et al.
Publicado: (2019)

Crystal Structure Reveals the Full Ras–Raf Interface and Advances Mechanistic Understanding of Raf Activation
por: Cookis, Trinity, et al.
Publicado: (2021)

Structure and RAF family kinase isoform selectivity of type II RAF inhibitors tovorafenib and naporafenib
por: Tkacik, Emre, et al.
Publicado: (2023)

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
por: Telang, Sucheta, et al.
Publicado: (2014)

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
por: Qin, Hongyu, et al.
Publicado: (2023)

Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
por: Bhargava, Ajay, et al.
Publicado: (2016)

A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression
por: Imoto, Hiroaki, et al.
Publicado: (2023)

Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
por: Scaini, Maria Chiara, et al.
Publicado: (2023)

Immunomodulatory Roles of PARP-1 and PARP-2: Impact on PARP-Centered Cancer Therapies
por: Yélamos, José, et al.
Publicado: (2020)

PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling
por: van Beek, Lotte, et al.
Publicado: (2021)

SNP discovery by high-throughput sequencing in soybean
por: Wu, Xiaolei, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0j8g34438m8tnvadra3ebsf2fu